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Abstract
Background: Mammalian receptors that couple to effectors via heterotrimeric G proteins (e.g.,
beta 2-adrenergic receptors) and receptors with intrinsic tyrosine kinase activity (e.g., insulin and
IGF-I receptors) constitute the proximal points of two dominant cell signaling pathways. Receptors
coupled to G proteins can be substrates for tyrosine kinases, integrating signals from both
pathways. Yeast cells, in contrast, display G protein-coupled receptors (e.g., alpha-factor
pheromone receptor Ste2) that have evolved in the absence of receptor tyrosine kinases, such as
those found in higher organisms. We sought to understand the motifs in G protein-coupled
receptors that act as substrates for receptor tyrosine kinases and the functional consequence of
such phosphorylation on receptor biology. We expressed in human HEK 293 cells yeast wild-type
Ste2 as well as a Ste2 chimera engineered with cytoplasmic domains of the beta2-adrenergic
receptor and tested receptor sequestration in response to activation of the insulin receptor
tyrosine kinase.
Results: The yeast Ste2 was successfully expressed in HEK 293 cells. In response to alpha-factor,
Ste2 signals to the mitogen-activated protein kinase pathway and internalizes. Wash out of agonist
and addition of antagonist does not lead to Ste2 recycling to the cell membrane. Internalized Ste2
is not significantly degraded. Beta2-adrenergic receptors display internalization in response to
agonist (isoproterenol), but rapidly recycle to the cell membrane following wash out of agonist and
addition of antagonist. Beta2-adrenergic receptors display internalization in response to activation
of insulin receptors (i.e., cross-regulation), whereas Ste2 does not. Substitution of the cytoplasmic
domains of the β2-adrenergic receptor for those of Ste2 creates a Ste2/beta2-adrenergic receptor
chimera displaying insulin-stimulated internalization.
Conclusion: Chimera composed of yeast Ste2 into which domains of mammalian G protein-
coupled receptors have been substituted, when expressed in animal cells, provide a unique tool for
study of the regulation of G protein-coupled receptor trafficking by mammalian receptor tyrosine
kinases and adaptor proteins.
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Background
G protein-coupled receptors (GPCR) are intrinsic mem-
brane proteins that transduce agonist binding into activa-
tion of heterotrimeric G proteins, a paradigm for cell
signaling extending from yeast to mammals [1]. The yeast
STE2 gene product is a heptahelical, GPCR that binds and
transduces intracellular signaling from the α-factor phe-
romone [2,3]. Recently we succeeded in expressing the
yeast  α-factor pheromone receptor Ste2 in human
HEK293 cells, demonstrating that Ste2 was fully func-
tional and capable of stimulating activation of the
mitogen-activated protein kinase Erk1/2 in response to α-
factor [4]. In yeast, activation of Ste2 leads to the internal-
ization, ubiquitination, and rapid degradation of this
GPCR. Unlike the situation in yeast cells, in HEK 293 cells
α-factor stimulates internalization of Ste2, but does not
lead to any significant reduction in the cellular comple-
ment of the receptor [4]. Yeast cells express no receptor
tyrosine kinases and Ste2 has evolved in their absence. We
expressed yeast α-factor pheromone receptors (Ste2) in
human HEK293 cells in order to employ Ste2 as a target
heptahelical receptors into which motifs found in mam-
malian GPCRs could be inserted in order to explore the
contribution(s) of the inserted domain(s) to receptor traf-
ficking by receptor tyrosine kinases.
Results
We tested if the internalized Ste2, not subject to rapid deg-
radation, recycled from the cytosolic compartment back
to the cell membrane once agonist action was terminated,
a property of most members of the superfamily of mam-
malian GPCRs [5]. HEK293 cells were transiently trans-
fected with either green fluorescent protein-tagged Ste2
(Ste2-GFP) or GFP-tagged β2AR (β2AR-GFP, figure 1) and
viewed by confocal microscopy. Expression of each recep-
tor was assayed by immunoblotting and radioligand
binding (not shown). In the absence of α-factor, Ste2 were
expressed largely on the cell membrane (figure 1; white
arrows highlight cell surface-localized receptors, Ste2-
GFP). Upon 30 min of stimulation with α-factor (figure 1;
α-factor, 10 μM, 0.5 h) the bulk of Ste2 was observed to
be internalized (figure 1; yellow arrowheads highlight
internalized receptors). Cells were washed free of agonist
and incubated with α-factor antagonist (des-Trp, Ala-3 α-
factor mutant, 10 μM) and the localization of Ste2 moni-
tored at 0.5, 1, 2, and 3 hours later (figure 1; washout + α-
factor antagonist). Internalized Ste2 remains localized in
the cytoplasmic compartment at each of these times fol-
lowing wash-out of agonist and addition of antagonist,
i.e., no significant recycling of the internalized Ste2 back
to the cell membrane was observed.
Like Ste2, β2AR-GFP expressed in HEK293 cells was
largely confined to the cell membrane (figure 1; white
arrows highlight cell surface-localized receptors). In the
presence of β-adrenergic agonist (figure 1; isoproterenol,
10 μM, 0.5 h), β2AR displays well-known agonist-induced
internalization (figure 1; yellow arrowheads highlight
internalized receptors). Wash-out of β-adrenergic agonist
and addition of a β-adrenergic antagonist (figure 1; wash-
out + propranolol, 10 μM), in sharp contrast to the situa-
tion observed for Ste2, was followed by a rapid and nearly
complete recycling of the β2AR to the cell membrane
within 3 hours. For these studies, the medium was supple-
mented with the protein synthesis inhibitor cyclohex-
imide (20 μg/ml) to suppress new synthesis of receptors.
Thus, the ability to express yeast Ste2 in mammalian cells
provides a novel template enabling study of receptor
motifs necessary for recycling of mammalian GPCRs from
the cytoplasmic compartment to the cell membrane.
Mammalian cells express members of the receptor tyro-
sine kinases, including epidermeal growth factor receptor,
insulin receptor, platelet-derived growth factor receptor,
and others that have been shown to regulate GPCRs via
tyrosine phosphorylation [6]. A prominent example of
regulation of GPCRs by receptor tyrosine kinases is the
well known insulin counterregulation of β2ARs [6]. When
expressed in HEK293 cells, β2ARs display tyrosine phos-
phorylation and rapid internalization in response to insu-
lin [6], as is observed in hamster vas deferens smooth
muscle cells, human A431 cells, and other cell lines [7]. As
shown by confocal microscopy (figure 2), β2AR-GFP is
localized to the cell membrane (figure 2, panel a; "Basal",
white arrows highlighting cell surface-localized recep-
tors). The β2AR are internalized in response to insulin
(100 nM, 0.5 h), although some cell surface-localized
β2AR are still observed following insulin stimulation (fig-
ure 2; panel b, see white arrows). The ability of receptor
tyrosine kinases that respond to insulin (shown), IGF-1
[8], and other growth factors to provoke the internaliza-
tion of GPCRs, such as the β2AR, is referred to as "counter-
regulation" [7].
Yeast cells, in contrast, do not express receptor tyrosine
kinases (e.g., epidermal growth factor receptor, insulin
receptor, and IGF-I receptor), making Ste2 an ideal target
for the study of the protein motifs through which mam-
malian tyrosine kinases regulate GPCRs. The Ste2-GFP is
localized to the cell membrane in unstimulated condi-
tions (figure 2; panel c), but unlike the β2AR does not
show internalization in response to insulin treatment (fig-
ure 2; panel d). The observed inability of insulin to regu-
late trafficking of Ste2 confirmed our base premise about
this yeast receptor and also created the opportunity to
employ the Ste2 GPCR as a model in which to probe the
protein motifs by which insulin, as well as other growth
factors, can regulate the internalization and recycling of
GPCR substrates.Journal of Molecular Signaling 2006, 1:2 http://www.jmolecularsignaling.com/content/1/1/2
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A chimeric receptor that makes use of the Ste2 exofacial
and transmembrane segments with substitution of the
cytoplasmic domains of Ste2 with those of the β2AR was
engineered and we tested if the Ste2/β2AR chimera would
enable insulin-stimulated internalization. The Ste2/β2AR
chimera, as presumed, lost its ability to transduce α-factor
stimulation into activation of the mitogen-activated pro-
tein kinases Erk1,2 (data not shown). The GFP-tagged
Ste2/β2AR chimera, studied by confocal microscopy, was
largely localized to the cell membrane (figure 2; panel e)
in the absence of added hormones. In response to stimu-
lation by insulin (100 nM) for 30 min, the β2AR displayed
marked internalization (figure 2; panel b); Ste2 did not
display any significant insulin-stimulated internalization
(figure 2; panel d). The Ste2/β2AR chimera, in contrast,
displayed prominent internalization in response to insu-
lin stimulation (figure 2; panel f). Evolving in the absence
of mammalian protein kinases and adaptor proteins oper-
ating in GPCR receptor trafficking [9], Ste2 provides a use-
ful target for molecular analysis of protein motifs that act
as substrates for tyrosine kinases and adaptor molecules.
Discussion
Ste2 was found to display agonist-induced internalization
in response to stimulation of the cells with α-factor, but
unlike the β2-adrenergic receptors (β2AR) and most other
GPCRs, failed to demonstrate recycling to the cell mem-
brane following removal of its agonist, providing a novel
system for investigation of the motifs critical for GPCR
recycling. Insulin stimulates, via activation of its receptor
tyrosine kinase and phosphorylation of its substrate
receptors [10], a counterregulation of GPCRs, including
the β2AR [11]. Yeast Ste2 expressed in animal cells, in con-
trast, does not display insulin-stimulated internalization,
Trafficking of yeast Ste2 in human HEK293 cells in response to α-factor: analysis by confocal microscopy Figure 1
Trafficking of yeast Ste2 in human HEK293 cells in response to α-factor: analysis by confocal microscopy. HEK 
cells were transiently transfected to express either Ste2-GFP or β2AR-GFP. Unstimulated cells display receptors that are 
largely localized to the cell membrane (white arrows denote cell membrane-localized receptors). Cells expressing yeast Ste2-
GFP and challenged with α-factor (10 μM, upper panel) as well as those expressing β2AR-GFP and challenged with beta-adren-
ergic agonist isoproterenol (Iso, 10 μM; lower panel) for 0.5 hr displayed frank internalization (yellow arrowheads denote 
internalized receptors). Agonist ligands were then washed from the media and the cells treated the appropriate antagonist lig-
and. Possible recycling of internalized receptors back to the cell membrane was followed for 3 hours. For cells expressing Ste2-
GFP, the a-factor antagonist (des-Trp, Ala-3 analog of a-factor, 10 μM) was added after wash-out and the cells were monitored 
at 0.5 (panel c), 1 (panel d), 2 (panel e), and 3 (panel f) hour time periods after wash-out of agonist. For cells expressing β2AR-
GFP, the β-adrenergic antagonist propranolol (10 μM) was added after wash-out of isoproterenol and the cells were moni-
tored at 0.5 (panel i), 1 (panel j), 2 (panel k), and 3 (panel l) hour time periods post wash-out of agonist. The images displayed 
are from a single experiment, representative of more than five replicate, separate experiments. Bar equals 10 μm.Journal of Molecular Signaling 2006, 1:2 http://www.jmolecularsignaling.com/content/1/1/2
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having evolved in the absence of receptor tyrosine kinases
of the nature of the insulin, EGF, IGF-I, and PDGF recep-
tors. A chimeric receptor composed of the exofacial and
transmembrane segments of Ste2 onto which the cyto-
plasmic domains of β2AR are substituted was engineered
and successfully expressed in animal cells. Unlike Ste2,
the chimeric receptor was found to display insulin-stimu-
lated internalization. These results provide a proof-of-
concept for the utility of yeast Ste2 expressed in animal
cells as a tool for study of mammalian protein kinases and
adaptors involved in GPCR trafficking.
Conclusion
The yeast pheromone Ste2 GPCR provides a useful exam-
ple of primitive receptor regulation, in the sense that the
receptor biology is almost linear from agonist binding to
receptor degradation, i.e., binding > activation > internal-
ization > ubiquitination > degradation by the proteo-
some. In higher organisms, additional new layers of
regulation can be observed in which retention of the
GPCR and/or its recycling from internalization are essen-
tial to maintaining proper signaling. Obviously, for neu-
rotransmitter receptors at the synapse, single-hit biology,
in which the receptor is activated and shortly thereafter
degraded, would pose an enormous problem for biosyn-
thetic capacity of the neuron. Resensitization and recy-
cling of internalized GPCRs is more the norm for the
mammalian systems and the central question arises, how
do mammalian cells regulate cell-surface retention times
and recycling capabilities? In the current work, we made
Trafficking of yeast Ste2, human β2AR, and a yeast Ste2/human β 2AR chimera expressed in human HEK293 cells in response  stimulation by insulin: analysis by confocal microscopy Figure 2
Trafficking of yeast Ste2, human β2AR, and a yeast Ste2/human β 2AR chimera expressed in human HEK293 
cells in response stimulation by insulin: analysis by confocal microscopy. HEK293 cells were transiently transfected 
to express either β2AR-GFP (panels a, b), Ste2-GFP (panels c, d), or the Ste2/β2AR-GFP chimeric receptor (panels e,f). For each 
of these GPCRs, localization of the receptors in the untreated cells was dominant at the cell membrane (white arrows). Cells 
were treated without (panels a, c, e) or with (panels b, d, f) insulin (100 nM) for 0.5 h and followed by confocal microscopy. 
Insulin stimulates internalization of the β2AR-GFP (panel b) and of the Ste2/β2AR-GFP chimeric receptor (panel f), but not of 
Ste2-GFP (panel d). The images displayed are from a single experiment, representative of more than five replicate, separate 
experiments. Bar equals 10 μm.Journal of Molecular Signaling 2006, 1:2 http://www.jmolecularsignaling.com/content/1/1/2
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use of the knowledge that yeast GPCRs operate in the
absence of input from receptor tyrosine kinases that are
well known to play essential roles in modulating GPCRs
in higher organisms. The yeast Ste2 provided a "clean"
slate, since once successfully expressed in animal cells, it
demonstrated functional downstream signaling and ago-
nist-induced internalization. But unlike the situation in
yeast cells, Ste2 internalization provoked neither rapid
destruction of this GPCR nor any obvious recycling of the
internalized receptor back to the cell membrane for reuti-
lization. Since regulation of GPCR trafficking by receptor
tyrosine kinases (e.g., insulin receptor) can involve direct
tyrosine phosphorylation of the GPCR as well as phos-
phorylation of the GPCR by downstream serine/threo-
nine protein kinases (e.g., protein kinase B/Akt),
understanding the full range of protein motifs, phospho-
rylations, and downstream interactions with adaptor pro-
teins (e.g., Grb2) may be best revealed by introducing
regions of targeted GPCRs into Ste2 and probing the reg-
ulation of the chimera in the animal cells. We succeeded
in conferring counterregulation by insulin to yeast Ste2 by
creating a chimera with cytoplasmic domains substituted
by the β2-adrenergic receptor. The protein kinases, phos-
phatases, and adaptor molecules necessary for resensitiza-
tion/recycling of mammalian GPCRs can be screened by
study of such internalized Ste2 chimera. We provide the
proof-of-concept for this strategy and suggest that Ste2
chimera may prove invaluable in many such efforts to
probe the structural determinants involved in affecting
GPCR cell surface retention times and GPCR recycling,
essential aspect of GPCR biology in higher organisms.
Methods
Plasmids
The STE2 gene was amplified by PCR by using plasmid
pDB02 [12] as the template and a pair of primers designed
with  NheI or BamHI linkers. The PCR product was
digested with NheI and BamHI and cloned into the unique
NheI/BamHI sites of peGFP-N1 expression vector (Clon-
tech). The plasmid encoding the enhanced GFP-tagged
human β2AR (in pCDNA3) has been fully characterized in
a variety of mammalian cell lines [13,14]. A chimeric
receptor (Ste2/β2AR) was generated by replacement of the
three cytoplasmic loops and the C-terminus of the Ste2
with the corresponding regions of the β2AR using overlap-
ping extension PCR and cloned into the NheI/BamHI sites
of the pEGFP-N1. The sequence of each construct was con-
firmed by DNA sequencing.
Cell culture and transfections
The human embryonic kidney HEK293 cells were main-
tained in Dulbecco's Modified Eagles Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS,
HyClone), penicillin (60 μg/mL) plus streptomycin (100
μg/mL), and grown in a humidified atmosphere of 5%
CO2 and 95% air at 37°C. For transfections, cells were
seeded at a density of 2 × 106 cells/100-mm dish, cultured
for 24 h, and transiently transfected using LipofectAMINE
(Invitrogen) according to the manufacturer's recommen-
dations. The cells then were cultured in the growth
medium for 48 h.
Confocal microscopy
For the confocal microscopy studies, cells expressing GFP-
tagged receptors were grown on Nunc® chambered cover-
glasses. Following an overnight serum starvation, cells
were treated as indicated and fixed with ice-cold methanol
for 2 min at -20°C. Images were taken with Zeiss 510
inverted confocal microscope (60×, oil immersion).
Images were imported as tiff.files, processed and prepared
in Adobe Photoshop© 5.5.
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